Role of beta-adrenergic blockers after percutaneous transluminal coronary angioplasty
- 1 October 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (12) , 915-920
- https://doi.org/10.1016/0002-9149(90)90925-q
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Effect of Short-Term Beta Blockade on Serum Lipid Levels and on the Interaction of LDL with Human Arterial ProteoglycansThe Journal of Clinical Pharmacology, 1990
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Percutaneous Transluminal Coronary Angioplasty in 1985–1986 and 1977–1981New England Journal of Medicine, 1988
- Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984
- Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.Circulation, 1983
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981